Chiba, Japan

Susumu Nishimura


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Ichihara, JP (1984)
  • Chiba, JP (1986 - 1994)

Company Filing History:


Years Active: 1984-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Susumu Nishimura

Introduction

Susumu Nishimura is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of five patents to his name, Nishimura's work has had a considerable impact on cancer treatment.

Latest Patents

Nishimura's latest patents include a novel 2-piperidinecarboxylic acid derivative, which is represented by a specific chemical formula. This compound has been shown to exert an antitumor effect over a wide range of tumor cells. Another significant patent involves 7-deazapurine derivatives, which are also useful as antitumor agents. These compounds possess potent antitumor activity and are designed to target various cancer types effectively.

Career Highlights

Throughout his career, Nishimura has worked with prominent companies in the pharmaceutical industry, including Takeda Chemical Industries, Inc. and Meiji Seika Kaisha, Ltd. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Nishimura has collaborated with esteemed colleagues such as Hiroaki Nomura and Hiroshi Akimoto. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in cancer research.

Conclusion

Susumu Nishimura's contributions to the field of pharmaceuticals, particularly in developing antitumor agents, highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire future research and development in this vital area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…